SFXN2 activators pertain to a class of chemical compounds that modulate the activity of the protein sideroflexin 2 (SFXN2), which is a member of the sideroflexin family. The proteins in this family are integral mitochondrial membrane proteins thought to be involved in the transport of serine, an amino acid that plays a role in various metabolic processes. SFXN2, in particular, has been implicated in the mitochondrial serine biosynthetic pathway, which is essential for numerous cellular functions including nucleotide synthesis, protein synthesis, and metabolic regulation. Activators of SFXN2 are compounds that enhance the activity of this protein, leading to an increase in the transport of serine into the mitochondria. The molecular mechanisms by which these activators work could involve alterations in the protein's structure, stability, or interactions with other molecules, thereby influencing its functionality and the serine uptake process.
The development of SFXN2 activators is grounded in a deep understanding of mitochondrial biology and the specific role of serine in cellular metabolism. These compounds are often the product of targeted chemistry efforts that exploit the unique characteristics of the SFXN2 protein structure. By identifying and optimizing small molecules that can bind to SFXN2 and enhance its transport activity, researchers can influence the concentration of serine within the mitochondria. This modulation is achieved through a variety of potential mechanisms, such as inducing conformational changes in the protein that increase its affinity for serine or by stabilizing the protein in a configuration that is more conducive to serine transport. The precise molecular interactions and the physicochemical properties of these activators are tailored to achieve selectivity for SFXN2, ensuring that they specifically augment the function of this protein without off-target effects on other sideroflexins or unrelated mitochondrial transporters.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A binds to cyclophilins and inhibits calcineurin, leading to the activation of NFAT (nuclear factor of activated T-cells) which can indirectly increase SFXN2 expression as part of the immune response. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, which may lead to phosphorylation events that enhance the functional activity of SFXN2 in metabolic pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in various signaling cascades. PKC activation can affect iron-sulfur cluster assembly proteins, potentially influencing SFXN2's activity as it is associated with mitochondrial iron homeostasis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors to modulate gene expression. It could enhance SFXN2 activity by upregulating genes associated with mitochondrial function and metabolism. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which plays a role in mitochondrial biogenesis and function. Through this pathway, insulin may indirectly enhance the activity of SFXN2 in energy metabolism. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has multiple cellular targets, including modulation of NF-κB signaling. By influencing this pathway, EGCG could indirectly enhance SFXN2 function related to cellular redox states and mitochondrial health. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which is involved in mitochondrial biogenesis and function. Through SIRT1 activation, resveratrol may indirectly enhance SFXN2 activity by improving mitochondrial health and metabolism. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine is known to induce autophagy and can lead to the removal of dysfunctional mitochondria, potentially increasing the demand for functional mitochondria and indirectly enhancing SFXN2 function in mitochondrial metabolism. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), which can enhance mitochondrial biogenesis and efficiency. This may indirectly enhance SFXN2's activity by increasing its functional demand in energy metabolism. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a coenzyme in redox reactions and sirtuin reactions. Boosting NAD+ levels can enhance mitochondrial function and possibly SFXN2's role in mitochondrial metabolism. | ||||||